Medical Industry Technology Near Micronesia

Statsols is the company behind nQuery. nQuery is the complete trial design platform to make clinical trials faster, less costly and more successful. For over 20 years, we have worked with biostatisticians and researchers all over the world to ensure ...

Datavant makes the world’s health data secure, accessible and usable. Datavant is a data platform company for healthcare whose products and solutions enable organizations to move and connect data securely. Through proprietary technology, the ...

Tryton Medical is a leading developer of novel stent systems for the treatment of bifurcation lesions. The co-founders of the company, Aaron V. Kaplan M.D. and H. Richard Davis, recognized an unmet need in coronary artery disease treatment. ...

The Spesana Healthcare platform is an intelligent overlay of existing systems that allows for all stakeholders in a patient's care the ability to connect without barriers thereby optimizing care. We are the team that developed the first oncology ...

We’re a precision diagnostics company that quantifies biology to create powerful molecular diagnostics. We work to improve disease detection by counting molecules with our proprietary molecular counting platform. We place patients at the forefront ...

Onegene Biotechnology develops transformative therapeutics for the chronic and complex diseases. Our UniStac platform allows rationale-based design of multispecific drug in true plug-and-play ...

Heart failure is a progressive disease. It’s an expensive disease. It’s a devastating disease. Over 20% of heart failure patients with FMR die within the first year of diagnosis and 50% die within five years.1 Each year thousands of these patients ...

AptaMatrix is a privately held, biotechnology company headquartered in Syracuse, New York. The company’s focus is to accelerate aptamer discovery using its patented Acyclic Identification of Aptamers™ (AIA™) & multiplexed AIA (mAIA™) approaches, ...

Curadigm is an early-stage company focused on shifting the paradigm of therapeutic clearance, bioavailability, and efficacy to improve treatment outcomes for millions of patients. Curadigm was spun-off from Nanobiotix, a late-stage clinical company, ...

Syngulon is a synthetic biology startup developing original genetic technologies using bacteriocins to improve microbial fermentation. Our team of scientists works in different academic laboratories and our R&D programs involve partners from ...

We are specialized in expanded primary cells and media (upcyte) as well as custom cell line development (ixcyte). Cells are our passion! If you are looking for a reliable partner for your project, we’ve got you covered. Our team of experienced ...

We are a late-stage biotech company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD). Our experienced and dedicated team is committed to making a difference in the lives of patients and their ...

Endotics: robotic disposable colonoscopy for safer and painless procedures - ''...All patients rated the robotic colonoscopy as virtually ...

Biolojic Design is committed to curing patients by designing and developing a pipeline of revolutionary therapeutics. Biolojic’s platform generates antibodies that bind to predefined epitopes, thus allowing for the design of specific functions: ...

Medtor is a early revenue-stage privately funded entity located in Manhattan Beach, CA and focused on leveraging patented optical technology to bring medical grade vital signs monitoring to wearable platforms. The company has already developed a ...

The founders have developed the present technology for the past 7 years. The team is currently developing predictors for fitness and health, powered by deep learning, for our present and future products. Located in the technological hub of Dublin, ...

Superfluid’s platform technology is applicable to a wide variety of diseases. We are currently focused on Alzheimer’s Disease, where there are urgent medical needs. This minimally invasive approach eliminates the need for spinal taps and ...

Orion Biotechnology is unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs) with a novel drug modality, proven discovery platform and best-in-class molecules. The company is advancing a diversified ...

We're a team of engineers, scientists, and physicians building the future of medical technology. Our goal is democratize tools for clinical decision support. We are alumni from Imperial College London, University College London, Oxford University, ...

Vaxxas is commercializing novel technology that dramatically enhances the performance of existing and next-generation vaccines. The company believes its innovative needle-free technology will be fundamental to help the world in rethinking what's ...